Medical Devices
FDA approves IDE for HYDRAFIL system in degenerative disc disease study
ReGelTec aims to start enrolment in early 2024 for the trial evaluating its disc-mimicking hydrogel injecting system.
ReGelTec aims to start enrolment in early 2024 for the trial evaluating its disc-mimicking hydrogel injecting system.